Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending booster shots.

The US Centers for Disease Control and Prevention's outside panel of vaccine experts this week discussed narrowing recommendations on the use of Covid-19 booster shots.

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

RSV typically causes cold-like symptoms, but is also a leading cause of pneumonia in toddlers and older adults. An estimated ...

As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from ...

Arexvy and Abrysvo are approved to prevent RSV-associated lower respiratory tract disease in adults aged 50 to 59 and 18 to ...

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...